NMR Verification of Structures of Bacterial Saccharide Precursors for Vaccines

疫苗用细菌糖前体结构的核磁共振验证

基本信息

项目摘要

About 40 monosaccharide and oligosaccharide intermediates for the preparation of a hexasaccharide-protein conjugate have been analyzed by high-resolution NMR at 500 MHz. The techniques used were: one-dimensional (1D) 1H and 1D 13C NMR. Two-dimensional (2D) methods such as COSY, TOCSY, and HSQC were also used in selected cases, if additional information on spectral assignments was needed. Validation of the chemical structures was based on integration of the 1D 1H NMR spectra, and on counting of carbon resonances in the 13C spectra, especially in well-separated spectral regions, such as those of the C=O, aromatic C, C-1, C-N, and C-CH3 moieties. 1D 13C Distortionless Enhancement by Polarization Transfer (DEPT) was also used to differentiate 13CH2 resonances from those of 13CH and 13CH3. This simple spectral editing technique yields a 13CH2 count in the form of 13C resonances of inverted phase, and was particularly applicable to these intermediates because of the mixed CH, CH2, CH3 resonances of the amide and linker side-chains in these structures. NMR service spectra measured at 500 MHz have been provided for the identification of 20 polysaccharide fragments isolated from Shigella sonnei, including products of nitrous acid deamination that are being used in structural studies, and spectra that facilitate detection of core polysaccharide in the samples. The techniques used include 1D 1H and 13C NMR, but sometimes 2D COSY, TOCSY, and HSQC, too. Acquisition of the spectra was performed at an elevated sample temperature of 50 C to reduce the viscosity of the solutions, thus permitting the measurement of sharper spectra. The techniques provide complex fingerprint spectra that can be compared with literature data to verify identity. Service spectra were also measured for nine fractions isolated from Klebsiella pneumoniae type 2, including a series of three samples of the polysaccharide that had been subjected to sonication for 5, 15, or 30 minutes to test a molecular weight reduction procedure. One sample of a polysaccharide found in S. flexneri type 2a has been identified by 1D 1H and 13C NMR.
用500 MHz的高分辨核磁共振分析了制备六糖-蛋白质偶合物所需的约40个单糖和低聚糖中间体。所使用的技术是:一维(1D)1H和1D 13C核磁共振。如果需要有关光谱分配的额外信息,也可以在选定的情况下使用COSY、TOCSY和HSQC等二维(2D)方法。化学结构的验证是基于1D 1H核磁共振谱的积分,以及13C谱中碳共振的计数,特别是在分离良好的谱区,如C=O、芳香C、C-1、C-N和C-CH3部分。一维13C极化转移无畸变增强(DEPT)也被用来区分13CH2和13CH3的共振。这种简单的光谱编辑技术以反相的13C共振的形式产生13CH2计数,并且特别适用于这些中间体,因为这些结构中的酰胺和连接体侧链的混合CH、CH2、CH3共振。 提供了在500 MHz下测量的核磁共振服务谱,用于鉴定从宋内氏志贺氏菌中分离出的20个多糖片段,包括用于结构研究的亚硝酸脱氨产物,以及有助于检测样品中核心多糖的光谱。使用的技术包括1D、1H和13C核磁共振,但有时也包括2D COSY、TOCSY和HSQC。光谱的采集是在50摄氏度的高温下进行的,以降低溶液的粘度,从而允许测量更清晰的光谱。这些技术提供了复杂的指纹图谱,可以与文献数据进行比较来验证身份。 还测量了从2型肺炎克雷伯氏菌分离出的九个组分的服务光谱,其中包括一系列三个样品的多糖,这些样品经过5、15或30分钟的超声波处理以测试分子量降低过程。 从2a型福氏志贺氏菌中分离得到一种多糖,经1D、1H和13C核磁共振确证。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

rachel schneerson其他文献

rachel schneerson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('rachel schneerson', 18)}}的其他基金

Peptide-Protein Conjugate Vaccines
肽-蛋白结合疫苗
  • 批准号:
    7334147
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Definition of Angular Dependence of 1H-15N Coupling Cons
1H-15N 联轴器角度依赖性的定义
  • 批准号:
    7334229
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Neonatal respiratory distress related to colonization wi
与定植相关的新生儿呼吸窘迫
  • 批准号:
    7334194
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Design, Synthesis & Testing Of Recombinant Proteins For
设计、合成
  • 批准号:
    7334231
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Peptide-Protein Conjugate Vaccines
肽-蛋白结合疫苗
  • 批准号:
    7594238
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Definition of Angular Dependence of 1H-15N Coupling Constants in Amino Sugars
氨基糖中 1H-15N 偶联常数的角度依赖性的定义
  • 批准号:
    7594245
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Peptide-Protein Conjugate Vaccines
肽-蛋白结合疫苗
  • 批准号:
    7212387
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Verification of the Structures of Bacterial Polysacchari
细菌多糖结构的验证
  • 批准号:
    7334230
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
D&P Replacement of DTP w/Genetically Inactivated Toxin
D
  • 批准号:
    7212388
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:
Lineage ST-17 complex group B strep. are more virulent t
谱系 ST-17 复合体 B 组链球菌。
  • 批准号:
    7334219
  • 财政年份:
  • 资助金额:
    $ 16.96万
  • 项目类别:

相似海外基金

Development of highly-efficient and safe live bacterial vaccines using viability-controlable pathogens
利用活性可控的病原体开发高效、安全的活细菌疫苗
  • 批准号:
    20H03158
  • 财政年份:
    2020
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Bacterial Vaccines and Therapies - Building a Product Pipeline
细菌疫苗和疗法 - 建立产品线
  • 批准号:
    700096
  • 财政年份:
    2012
  • 资助金额:
    $ 16.96万
  • 项目类别:
    GRD Proof of Market
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
针对生物防御剂的重组减毒细菌疫苗
  • 批准号:
    8259119
  • 财政年份:
    2011
  • 资助金额:
    $ 16.96万
  • 项目类别:
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
针对生物防御剂的重组减毒细菌疫苗
  • 批准号:
    8653527
  • 财政年份:
    2011
  • 资助金额:
    $ 16.96万
  • 项目类别:
Designing effective Gram negative bacterial vaccines
设计有效的革兰氏阴性细菌疫苗
  • 批准号:
    DP110104165
  • 财政年份:
    2011
  • 资助金额:
    $ 16.96万
  • 项目类别:
    Discovery Projects
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
针对生物防御剂的重组减毒细菌疫苗
  • 批准号:
    8075999
  • 财政年份:
    2011
  • 资助金额:
    $ 16.96万
  • 项目类别:
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
针对生物防御剂的重组减毒细菌疫苗
  • 批准号:
    8463108
  • 财政年份:
    2011
  • 资助金额:
    $ 16.96万
  • 项目类别:
Live Attenuated Bacterial Vaccines Against Plaque
抗斑块减毒活细菌疫苗
  • 批准号:
    7882500
  • 财政年份:
    2008
  • 资助金额:
    $ 16.96万
  • 项目类别:
Live Attenuated Bacterial Vaccines Against Plaque
抗斑块减毒活细菌疫苗
  • 批准号:
    7603014
  • 财政年份:
    2008
  • 资助金额:
    $ 16.96万
  • 项目类别:
Live Attenuated Bacterial Vaccines Against Plaque
抗斑块减毒活细菌疫苗
  • 批准号:
    8056651
  • 财政年份:
    2008
  • 资助金额:
    $ 16.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了